Maron, R., Schechter, B., Mancini, M., Mahlknecht, G., Yarden, Y., Sela, M. (2013) Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2. Proceedings of the National Academy of Sciences, 110 (38) 15389-15394 doi:10.1073/pnas.1313857110

See Also

These are possibly similar items as determined by title/reference text matching only.

	Mahlknecht, G., Maron, R., Mancini, M., Schechter, B., Sela, M., Yarden, Y. (2013) Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth. Proceedings of the National Academy of Sciences, 110 (20) 8170-8175 doi:10.1073/pnas.1302594110
	Ben-Kasus, T., Schechter, B., Lavi, S., Yarden, Y., Sela, M. (2009) Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: Relevance of receptor endocytosis. Proceedings of the National Academy of Sciences, 106 (9) 3294-3299 doi:10.1073/pnas.0812059106
	Ferraro, D. A., Gaborit, N., Maron, R., Cohen-Dvashi, H., Porat, Z., Pareja, F., Lavi, S., Lindzen, M., Ben-Chetrit, N., Sela, M., Yarden, Y. (2013) Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR. Proceedings of the National Academy of Sciences, 110 (5) 1815-1820 doi:10.1073/pnas.1220763110
	Hurwitz, E., Stancovski, I., Sela, M., Yarden, Y. (1995) Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake. Proceedings of the National Academy of Sciences, 92 (8) 3353-3357 doi:10.1073/pnas.92.8.3353
	Friedman, L. M., Rinon, A., Schechter, B., Lyass, L., Lavi, S., Bacus, S. S., Sela, M., Yarden, Y. (2005) Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: Implications for cancer immunotherapy. Proceedings of the National Academy of Sciences, 102 (6) 1915-1920 doi:10.1073/pnas.0409610102
	Klapper, L. N., Glathe, S., Vaisman, N., Hynes, N. E., Andrews, G. C., Sela, M., Yarden, Y. (1999) The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. Proceedings of the National Academy of Sciences, 96 (9) 4995-5000 doi:10.1073/pnas.96.9.4995
	Lindzen, Moshit, Lavi, Sara, Leitner, Orith, Yarden, Yosef (2010) Tailored cancer immunotherapy using combinations of chemotherapy and a mixture of antibodies against EGF-receptor ligands. Proceedings of the National Academy of Sciences, 107 (28) 12559-12563 doi:10.1073/pnas.1006218107
	Arnon, R., Maron, E., Sela, M., Anfinsen, C. B. (1971) Antibodies Reactive with Native Lysozyme Elicited by a Completely Synthetic Antigen. Proceedings of the National Academy of Sciences, 68 (7) 1450-1455 doi:10.1073/pnas.68.7.1450
	Stancovski, I., Hurwitz, E., Leitner, O., Ullrich, A., Yarden, Y., Sela, M. (1991) Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth. Proceedings of the National Academy of Sciences, 88 (19) 8691-8695 doi:10.1073/pnas.88.19.8691
	Vistein, R., Puthenveedu, M. A. (2013) Reprogramming of G protein-coupled receptor recycling and signaling by a kinase switch. Proceedings of the National Academy of Sciences, 110 (38) 15289-15294 doi:10.1073/pnas.1306340110
	Maron, R., Jackson, R. A., Jacobs, S., Eisenbarth, G., Kahn, C. R. (1984) Analysis of the insulin receptor by anti-receptor antibodies and flow cytometry. Proceedings of the National Academy of Sciences, 81 (23) 7446-7450 doi:10.1073/pnas.81.23.7446